Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol

Chemotherapy. 1977;23(2):121-8. doi: 10.1159/000221980.

Abstract

67 of the bacteriologically proved adult acute cholera patients have been examined in order to evaluate the efficacy of TM-SMX in comparison with tetracycline and chloramphenicol in the eradication of Vibrio cholerae from stools. Our results demonstrated that all three drugs sterilized the stools of all patients within 3 days with the exception of one case of TM-SMX's group, which had negative culture stools after 4 days. On the basis of our experience it can be emphasized that TM-SMX can support chloramphenicol and tetracycline in the antibacterial treatment of cholera with the advantage that the drug is efficacious with daily administrations.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Chloramphenicol / therapeutic use*
  • Cholera / drug therapy*
  • Drug Combinations
  • Drug Evaluation
  • Feces / microbiology
  • Humans
  • Sulfamethoxazole / therapeutic use*
  • Tetracycline / therapeutic use*
  • Trimethoprim / therapeutic use*
  • Vibrio cholerae / isolation & purification

Substances

  • Drug Combinations
  • Chloramphenicol
  • Trimethoprim
  • Tetracycline
  • Sulfamethoxazole